Market Segmentation
- U.S. Oligonucleotide Synthesis Product & Service Outlook (Revenue, USD Million, 2018 - 2030)
- Oligonucleotides
- DNA
- Column-based
- Array-based
- RNA
- By Technology
- Column-based
- Array-based
- By Type
- Short RNA Oligos (<65 nt)
- Long RNA Oligos (>65 nt)
- CRISPR (sgRNA)
- Equipment/Synthesizer
- Reagents
- Services
- DNA
- Custom Oligo Synthesis Services
- 25 nmol
- 50 nmol
- 200 nmol
- 1000 nmol
- 10000 nmol
- Modification Services
- Purification Services
- RNA
- Custom Oligo Synthesis Services
- 25 nmol
- 100 nmol
- 1000 nmol
- 10000 nmol
- Modification Services
- Purification Services
- U.S. Oligonucleotide Synthesis Application Outlook (Revenue, USD Million, 2018 - 2030)
- PCR Primers
- PCR Assays and Panels
- Sequencing
- DNA Microarrays
- Fluorescence In Situ Hybridization (FISH)
- Antisense Oligonucleotides
- Other Applications
- U.S. Oligonucleotide Synthesis End-use Outlook (Revenue, USD Million, 2018 - 2030)
- Academic Research Institutes
- Diagnostic Laboratories
- Pharmaceutical & Biotechnology Companies
Report content
Qualitative Analysis
- Industry overview
- Industry trends
- Market drivers and restraints
- Market size
- Growth prospects
- Porter’s analysis
- PESTEL analysis
- Key market opportunities prioritized
- Competitive landscape
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments
Quantitative Analysis
- Market size, estimates, and forecast from 2018 to 2030
- Market estimates and forecast for product segments up to 2030
- Country market size and forecast for product segments up to 2030
- Market estimates and forecast for application segments up to 2030
- Country market size and forecast for application segments up to 2030
- Company financial performance
We are committed towards customer satisfaction, and quality service.
"The quality of research they have done for us has been excellent."
Brian Moore, VP, NICCA USA, Inc.
testimonialsMore
